HLB Life Science CO.,LTD.

067630· KOSDAQ· Health Care· Health Care Equipment & Services

₩2,430-5.63%

2026-09-18

Financials

Valuation Metrics

HLB Life Science CO.,LTD.'s Market Cap is ₩2963B. At end of 2025 it was ₩4724B. Ranked #668 of 2,421 in KR market (top 28%), #278 of 1,640 on KOSDAQ (top 17%), #19 of 96 in Health Care Equipment & Services (top 20%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	296.26B KRW	KR#668/2,421 Sec#19/96
Revenue	36.36B KRW	KR#1,959/2,421 Sec#60/96
Net Income	-33.14B KRW	KR—/2,421 Sec—/96
Total Assets	468.40B KRW	KR#800/2,421 Sec#13/96
Net Assets	282.46B KRW	KR#743/2,421 Sec#15/96
Employees	169	KR#1,224/2,421 Sec#39/96
Value
P/B	1.05x	KR#1,506/2,421 Sec#45/96
P/S	8.15x	KR#2,241/2,421 Sec#82/96
FCF Yield	-16.38%	KR—/2,421 Sec—/96
Profitability
ROE	-11.73%	KR#1,973/2,421 Sec#70/96
ROA	-7.07%	KR#2,014/2,421 Sec#70/96
Op. Margin	-64.49%	KR#2,262/2,421 Sec#82/96
Revenue Growth	-61.32%	KR#2,308/2,421 Sec#93/96
Financial Health
Debt Ratio	65.83%	KR#1,163/2,421 Sec#66/96
Total Debt	156.72B KRW	KR#592/2,421 Sec#10/96
FCF	-48.51B KRW	KR#2,079/2,421 Sec#81/96
Cash	10.11B KRW	KR#1,692/2,421 Sec#55/96
Current Ratio	0.57x	KR#2,095/2,421 Sec#88/96
Performance
1Y Return	-30.17%	KR#1,565/2,421 Sec#42/96
1M Return	-21.74%	KR#2,311/2,421 Sec#89/96
From 52W High	-54.41%	KR#1,617/2,421 Sec#49/96
1Y MDD	-68.16%	KR#1,909/2,421 Sec#66/96
Trading
Volume	146,358 shares	KR#605/2,421 Sec#21/96
Trading Value	359.0M KRW	KR#1,064/2,421 Sec#36/96
Foreign Own.	5.32%	KR#819/2,421 Sec#26/96
Per Share
EPS	-272 KRW	KR—/2,421 Sec—/96
BPS	2,317 KRW	KR#2,001/2,421 Sec#65/96

Company Info

CEO 남상우

Employees 169

Founded 1998

HQ 경기도 화성시, KR

Website www.hlb-ls.com

동사는 1998년 설립, 2008년 코스닥 상장 후 2015년 에이치엘비생명과학으로 변경했으며, 2023년 화진메디칼 합병을 완료함. 2025년 티니코 지분 100% 인수로 의료기기 사업 확대함. 메디케어 분야에서는 의료기기 개발·제조와 위탁생산을, 의료기기 분야에서는 주사기 제조·판매를, 바이오개발 분야에서는 표적항암제·바이오인공간을, 에너지 분야에서는 태양광 EPC·폐기물 소각열 사업을 하고 있음. HLB생명과학는 1998년에 설립되었으며 경기도 화성시에 본사를 두고 있습니다.